Mira Pharmaceuticals files for $16M IPO

Mira Pharmaceuticals, a pre-clinical cannabis pharmaceuticals developer, has filed to list its common shares on NASDAQ. On Thursday (June 29), Mira filed to raise $16.4m in an IPO to fund the development of its lead drug candidate MIRA1a. According to the Baltimore-based company, this is a ‘new